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Holstein steers (n = 16) were used to determine if a synthetic alkaloid, bromocriptine,
would alter the transcriptome of the small intestine and adjacent mesenteric adipose.
On d 0, steers were assigned to one of two treatments: control (CON; saline only) or
bromocriptine (BROMO; 0.1 mg/kg BW bromocriptine mesylate injected intramuscularly
every 3 d for 30 d). Steers were slaughtered and midpoint sections of jejunal epithelium
and associated mesenteric fat were collected for RNA isolation. Transcriptome analysis
was completed via RNA-Seq to determine if BROMO differed compared with CON
within intestinal epithelium or mesenteric adipose mRNA isolates. Differential expression
thresholds were set at a significant P-value (P < 0.05) and a fold change ≥ 1.5. Only
two genes were differentially expressed within the intestinal epithelium but there were
20 differentially expressed genes in the mesenteric adipose tissue (six up regulated and
14 down regulated). Functions related to cell movement, cell development, cell growth
and proliferation, cell death, and overall cellular function and maintenance were the top
five functional molecular categories influenced by BROMO treatment within the intestinal
epithelium. The top molecular categories within mesenteric adipose were antigen
presentation, protein synthesis, cell death, cell movement, and cell to cell signaling and
interaction. In conclusion, BROMO treatment influenced the intestinal epithelium and
mesenteric adipose transcriptome and identified genes and pathways influential to the
effects associated with alkaloid exposure which are important to beef production.
Keywords: adipose, alkaloids, intestine, ruminants, transcriptome
INTRODUCTION
Tall fescue (Lolium arundinaceum) makes up a sizable portion of the grazing land in the
United States and can reduce costs due to increased persistence and drought tolerance. The
hardiness of tall fescue is attributed to the presence of an endophyte infection (Epichloë
coenophiala). This symbiotic relationship between the plant and endophyte increases the
sustainability of pastures and increases tall fescues usefulness as a grazing feed source (1). However,
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tall fescue infected with endophyte decreases animal productivity
due to ergot alkaloid ingestion from the endophyte infected
plants (2, 3). Ingestion of ergot alkaloids from the plant itself (4,
5) and alkaloids produced by the fungi that infect tall fescue (6)
have been implicated in fescue toxicosis. Animals experiencing
fescue toxicosis exhibit a variety of symptoms such as increased
respiration, impaired immune function, reduced feed intake,
and decreased weight gain (7–10). Cattle grazing tall fescue
exhibit an unhealthy appearance even after access to fescue has
ceased but can experience compensatory gains with increased
diet quality (9). Stuedemann and Hoveland (11) proposed that
fescue toxicosis can alter lipid metabolism, adipose composition,
and increase the occurrence of necrotic fat depots. However,
instances of necrotic fat have only been reported in the abdominal
fat depots (8) and mainly in older cattle which have grazed
endophyte infected fescue over long periods of time.
Ergot alkaloids have been reported to inhibit prolactin
secretion in cattle (12, 13). However, ergot alkaloid levels vary
greatly in feedstuffs and make consistent exposure difficult in
experimental procedures. Bromocriptine is a dopamine receptor
agonist that effectively inhibits prolactin secretion (14) similar
to ergot alkaloids. Lactating cows fed endophyte-infected fescue
or treated with bromocriptine had over 90% of differentially
expressed genes (>850 genes) influenced in a similar manner
when compared with control cows (15). Doses of bromocriptine
have ranged from 15 to 80 mg/animal, and treatment frequencies
have ranged from two times a day to three times per week (16–
20) but provide a model to decrease prolactin and initiate fescue
toxicosis symptoms in cattle with much greater control by not
relying on animal intake. Thus, the hypothesis of this study
was that ergot alkaloid exposure via bromocriptine treatment
would impact the transcriptome of the intestinal epithelium and
mesenteric adipose tissue relevant to beef production of growing
Holstein steers without impacting feed intake.
MATERIALS AND METHODS
All animal procedures were conducted with approval from the
Institutional Animal Care and Use Committee at the University
of Kentucky (Protocol # 01065A2006).
Animals
Holstein steers [n = 16; initial body weight (BW) 313 ± 16 kg]
were used to determine if the synthetic alkaloid, bromocriptine,
at levels known to induce fescue toxicosis symptoms (20) would
alter the transcriptome of the jejunal epithelium and the adjacent
mesenteric adipose. Steers were housed in individual pens (3
× 3m) within a temperature-controlled research facility and
allowed 3 d to adjust to being housed indoors prior to the
initiation of the study (d 0). Steers were maintained on a total
mixed ration of 61% corn silage, 24% cracked corn, 5% dry
distiller’s grains with solubles, and 10% soybeanmeal supplement
with 150 mg/head/d rumensin. The overall diet was 49% dry
matter, had a net energy for maintenance of 0.367 Mcal/kg,
contained 13% crude protein, and was fed to provide 1.5 × net
energy for maintenance daily. Maintenance was determined by
multiplying empty BW raised to the 0.75 power by 0.77 and
increased by 20% to address the increased maintenance energy
requirement for dairy animals (21).
On d 0 steers were randomly assigned to one of two
treatments: control (CON) or bromocriptine (BROMO). Control
animals were intramuscularly injected in the injection triangle
of the neck with saline and ethanol (60 and 40%, respectively)
at a similar volume to BROMO (∼5mL) every 3 d to coincide
with bromocriptine injections. Animals who were assigned
to BROMO received bromocriptine mesylate (Santa Cruz
Biotechnology; Dallas, TX) at 0.1 mg/kg BW every 3 d beginning
on d 0 and ending on d 27 resulting in 10 intramuscular
injections. Bromocriptine was reconstituted as working stock
in 95% ethanol and diluted with saline so no more than 40%
ethanol was given in a single injection. The concentration of
BROMO was determined in a previous study where BROMO
give at this dosage elicited the same gene expression response
in 90% of differentially expressed genes in mammary tissue (n =
866) identified comparing the BROMO treatment response with
the response observed in cows fed endophyte-infected fescue
seed (15). Body weights were taken weekly to ensure feed was
provided at 1.5 ×maintenance and injection volumes calculated
properly. Feed and water intake was individually provided and
recorded daily. Orts were weighed daily prior to feeding to
calculate daily intake for the previous 24 h. Steers were kept
on automatic waterers that were equipped with a water meter
to capture water intake. Daily water intake was recorded prior
to feeding. Circulating levels of prolactin were used to confirm
treatment effect on animal did in fact induce similar effects
to fescue toxicosis. Blood samples were taken prior to feeding
via jugular venipuncture with 10mL vacutainer tubes (Becton
Dickinson Co.; Franklin Lakes, NJ) upon entry into the housing
facility (d−3) and d 0, 7, 14, 21, and 28 to ensure BROMO treated
steers had decreased systemic prolactin concentrations. Serum
prolactin concentrations were quantified via radioimmunoassay
according to procedures previously described (22). The intra
and inter assay CVs were 5.35 and 4.37%, respectively, with a
sensitivity of 0.05 ng/mL. Prolactin concentrations were analyzed
within the mixed procedure of SAS (SAS Institute, Cary, NC)
with repeated measures and a compound symmetry covariance
structure. The model included treatment, day and the interaction
of treatment× day and block as a random covariate. The repeated
statement had day as the variable and animal within block as the
subject. Least square means were used to separate main effect
means with significance set as P < 0.05.
On d 30, at 07:00 h the steers were transported 26.7 km
from the animal research center beef unit to the meats
laboratory at the University of Kentucky. After exsanguination
the gastrointestinal tract was removed from the body cavity as
quickly as possible (<10min). The gastrointestinal tract was
separated into the forestomach complex (rumen, reticulum,
omasum, and abomasum), small intestine, and large intestine.
The small intestine was looped over a peg board and a 10 cm
section was removed 7m from the cranial end. Mesenteric
adipose adjacent to the 10 cm intestinal section was also removed
for further processing. Following separation from the entire
tract, 50mg of adipose tissue submerged in RNAlater (Thermo
Fisher Scientific; Waltham, MA) and flash frozen in liquid
Frontiers in Veterinary Science | www.frontiersin.org 2 September 2020 | Volume 7 | Article 615
McLean et al. Bromocriptine Influence on Bovine Transcriptome
nitrogen. The small intestinal lumen was exposed, the epithelium
was scraped away from the other intestinal tissue layers, and
50mg of epithelium was submerged in RNAlater (Thermo Fisher
Scientific) and flash frozen in liquid nitrogen.
RNA Isolation and Library Construction
Both jejunum and mesenteric adipose samples were isolated
using RNeasy Plus Mini Kit (Qiagen, Valenica, CA). Quality
check was performed using Tapestation RNA HS Assay (Agilent
Technologies, Santa Clara, CA) and quantified by Qubit RNA
HS assay (ThermoFisher Scientific, Waltham, MA). The RNA
integrity number for samples was lower and more variable than
expected (2.6 ± 0.6 for intestine and 5.0 ± 1.3 for adipose);
thus, ribosomal RNA depletion was performed with Ribo-zero
Magnetic Gold Kit (Illumina Inc., San Diego, CA) to ensure
RNA isolated was of the highest possible quality. Samples
were randomly primed and fragmented based on manufacturer’s
recommendation (NEBNext R© UltraTM RNA Library Prep Kit
for Illumina R©; Illumina Inc., San Diego, CA). The first strand
was synthesized with the Protoscript II Reverse Transcriptase
for 40min at 42◦C. Synthesis of second strand cDNA was then
carried out and products were amplified by PCR to create the
cDNA library for each sample. All remaining steps for library
construction were done according to the NEBNext R© UltraTM
RNA Library Prep Kit for Illumina R© (Illumina Inc.). Illumina 8-
nt dual-indices were used. Samples were pooled by animal and
sequencing was done on a HiSeq with a read length configuration
of 150 paired end base pairs with up to 50 million reads
per sample.
Bioinformatic Analysis
Intestinal and adipose library preparation and sequencing, was
performed using FASTQC (version v0.11.3). A splice aware
aligner, STAR (version 2.5.2b), was used to perform RNA-
Seq alignment. The UMD3.1 and UMD3.1.90 from Ensembl
were used as genome reference and annotation reference,
respectively, during the alignment. Then dupRader and Picard
CollectRnaSeqMetrics (version 2.10.5) were used to evaluate
duplicates level and overall alignment performance. HT-Seq
(version 0.0.6) was used to calculate the per gene expression
count. DE-Seq2 was used to estimate differentially expressed
genes, all genes are listed in Supplementary Table 1. This list
of genes was uploaded into Ingenuity Pathway Analysis (IPA,
Qiagen) for further analyses (Supplementary Table 2).
Ingenuity Pathway Analysis
Differentially expressed genes from RNA-Seq were analyzed
via IPA according to previously described methods (23–25).
The RNA-Seq data was used by IPA to identify new gene
targets, biological mechanisms, pathways, and functions, and
candidate biomarkers. Datasets uploaded into the IPA software
consisted of all genes identified as significant with a P ≤ 0.10
(Supplementary Table 2). From these datasets the most relevant
genes were identified as differentially expressed genes (DEG). To
qualify as a DEG, genes had to have a significant P-value and
a positive or negative fold change of >1.5. Canonical pathway
analysis identified the most significantly influenced canonical
FIGURE 1 | Circulating prolactin concentrations in plasma of control (CON)
and bromocriptine (BROMO) treated steers. BROMO prolactin means were
different from CON within a given day (P < 0.05) and are depicted by an * (d 7,
14, 21, and 28, respectively). Time is in relation to the initiation of BROMO
treatments (d = 0). The standard error for all data was 2.64.
pathways from the IPA library within each tissue. Genes related
to each canonical pathway were considered for further analysis.
Two measurements are evaluated for canonical pathway analysis
(1) the ratio of the number of genes from the data set that map
to the pathway divided by the total number of genes that map to
the canonical pathway and (2) the Fisher’s exact test was used to
calculate a P-value for the genes in the dataset and the identified
canonical pathway. Networks of DEG were then algorithmically
generated based on their connectivity. These genes were overlaid
onto a global molecular network from the IPA library. Functional
analysis identified biological functions associated with DEG that
were most significantly influenced by treatment within a tissue. A
right-tailed Fisher’s exact test was used to calculate a P-value for
each biological function and/or disease.
RESULTS
Circulating prolactin concentrations were similar (P >
0.11) between BROMO and Con steers prior to treatment
initiation, d −3 and 0 (Figure 1). However, as expected, plasma
concentrations were dramatically reduced (P = 0.003) in
BROMO steers compared with CON steers at all-time points
following bromocriptine administration, d 7, 14, 21, and 28.
Threshold for determination of DEG was set at a significant P-
value (P < 0.05) and a fold change of >1.5. Based on selection
criteria, RNA-Seq analysis revealed 15 DEG that were down
regulated in BROMO compared with CON; one DEG within the
intestinal epithelium, fatty acid binding protein 4, and 16 DEG
in the mesenteric adipose tissue (Table 1). Analysis identified 7
DEG were identified to be up regulated in BROMO compared
with CON; 6 in the mesenteric and UDP-GlcNAc:betaGal Beta-
1,3-N-Acetylglucosaminyltransferase in the intestinal epithelium
(Table 2).
The canonical pathways influenced by BROMO treatment
are listed in Table 3. These pathways were determined to be
influenced from the all significant (P < 0.05) genes with
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TABLE 1 | Differentially expressed genes* that were down regulated after exposure to Bromocriptine in the intestinal epithelium and mesenteric adipose tissue of
Holstein steers.
Symbol Gene name Fold change Tissue type P-value Location Type
FABP4 Fatty Acid Binding Protein 4 1.842 Intestinal 0.020 Cytoplasm Transporter
CYP4F2 Cytochrome P450 Family 4 Subfamily F Member 2 5.448 Adipose 0.048 Cytoplasm Enzyme
C8A Complement C8 Alpha Chain 5.14 Adipose 0.019 Extracellular Other
ASIC5 Acid Sensing Ion Channel Subunit Family Member 5 5.021 Adipose 0.041 PM† Ion Channel
GLT1D1 Glycosyltransferase 1 Domain Containing 1 4.965 Adipose 0.0278 Extracellular Enzyme
SERPINB2 Serpin Family B Member 2 4.924 Adipose 0.053 Extracellular Other
AICDA Activation Induced Cytidine Deaminase 4.902 Adipose 0.040 Cytoplasm Enzyme
CDH16 Cadherin 16 4.83 Adipose 0.040 PM Enzyme
CXCL2 C-X-C Motif Chemokine Ligand 2 4.436 Adipose 0.039 Extracellular Cytokine
CHGB Chromogranin B 4.356 Adipose 0.023 Extracellular Other
SLC26A5 Solute Carrier Family 26 Member 5 4.037 Adipose 0.029 PM Transporter
HEPACAM2 HEPACAM Family Member 2 4.014 Adipose 0.050 Cytoplasm Other
NR1H4 Nuclear Receptor Subfamily 1 Group H Member 4 3.862 Adipose 0.019 Nucleus LDNR‡
SLC9A2 Solute Carrier Family 9 Member A2 3.628 Adipose 0.027 PM Transporter
LEAP2 Liver Enriched Antimicrobial Peptide 2 3.473 Adipose 0.051 Extracellular Other
DTHD1 Death Domain Containing 1 2.326 Adipose 0.054 Other Other
CD8A CD8a Molecule 1.535 Adipose 0.042 PM Other
*Differentially expressed genes listed above were limited to those with a P-value <0.05 and >1.5 fold change.
†
PM, Plasma Membrane.
‡
LDNR, ligand-dependent nuclear receptor.
TABLE 2 | Differentially expressed genes* that were up regulated after exposure to Bromocriptine in the intestinal epithelium and mesenteric adipose tissue of
Holstein steers.
Symbol Gene name Fold change Tissue type P-value Location Type
B3GNT6 UDP-GlcNAc:betaGal
Beta-1,3-N-Acetylglucosaminyltransferase 6
2.853 Intestinal 0.006 Cytoplasm Enzyme
MOXD1 Monooxygenase DBH Like 1 1.772 Adipose 0.040 Cytoplasm Enzyme
SORCS2 Sortilin Related VPS10 Domain Containing Receptor 2 1.833 Adipose 0.047 PM† Transporter
SLC11A1 Solute Carrier Family 11 Member 1 1.988 Adipose 0.043 PM Transporter
LY6G5B Lymphocyte Antigen 6 Family Member G5B 2.042 Adipose 0.050 Other Other
DNER Delta/Notch Like EGF Repeat Containing 3.558 Adipose 0.027 PM Transmembrane
Receptor
PF4 Platelet Factor 4 5.393 Adipose 0.007 Extracellular
Space
Cytokine
*Differentially expressed genes listed above were limited to those with a P-value <0.05 and >1.0 fold change.
†
PM, Plasma Membrane.
and without a 1.5 fold change within the datasets (BROMO
and CON) via IPA library. In the intestinal epithelium and
mesenteric adipose, LXR/RXR activation, granulocyte adhesion,
and diapedesis were depressed (P < 0.001) in BROMO steers.
Atherosclerosis and high mobility group box 1 (HMGB1)
signaling and the inflammasome pathway were also depressed
(P < 0.001) in the intestinal epithelium of BROMO steers
compare with CON steers. In the mesenteric adipose, LPS/IL-
1 mediated inhibition of RXR function, FXR/RXR activation,
antigen presentation, IL-6 signaling, dendritic cell maturation,
and serotonin degradation were all depressed (P < 0.001) by
BROMO treatment (Table 3).
The top 5 upstream regulators were different between the
intestinal epithelium and mesenteric adipose (Tables 4, 5).
However, upstream regulation by IL 1A, IL 2, IL 4, IL 6, IL 18, IGF
1, growth hormone (GH), extracellular signal–regulated kinases
1/2 (ERK1/2), and toll-like receptor 4 (TLR 4) were found in the
top 30 upstream regulators for both tissue types. In the intestinal
epithelium, regulator of G protein signaling (RGS2), MAPK 9,
prostaglandin-endoperoxide synthase 2 (PTGS2), proteinase 3
(PRTN3), and histidine rich glycoprotein (HRG) were found to
be the top 5 upstream regulators (Table 4). In the mesenteric
adipose, TNF, interferon α receptor (IFNαR), IL 1B, NF-κβ,
and IFNγ were found to be the top five upstream regulators
(Table 5). Also, prolactin, which is depressed by BROMO
treatment (Figure 1), was identified as an upstream regulation of
the transcriptome in the mesenteric adipose of BROMO steers
(Table 5).
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TABLE 3 | Canonical pathways influenced by treatment with bromocriptine in the intestinal epithelium and mesenteric adipose in Holstein steers.
Pathway P-value Ratio* Genes†
Intestinal epithelium
LXR/RXR Activation < 0.0001 0.033 ↓CCL2, ↓IL18, ↓LPL, ↓MMP9
Atherosclerosis Signaling < 0.0001 0.031 ↓CCL2, ↓IL18, ↓LPL, ↓MMP9
Inflammasome Pathway 0.0001 0.100 ↓IL18 and ↑NLRP1
HMGB1‡ Signaling 0.0001 0.023 ↓CCL2, ↓IL18, ↑PLAT
Granulocyte Adhesion and Diapedesis 0.0003 0.017 ↓CCL2, ↓IL18, ↓MMP9
Mesenteric adipose
LPS/IL-1 Mediated Inhibition of RXR Function < 0.0001 0.054 ↓ABCB11; ↓ALAS1; ↓ALDH1L1, 8A1; ↓FABP7; ↓IL1A; ↓NR1H4; ↓PAPSS2; ↓PLTP; ↓SULT2A1;
↑IL1RL1; ↑SULT1A1
FXR/RXR Activation < 0.0001 0.071 ↓ABCB11; ↓APOA4, B; ↓IL1A; ↓NR1H4; ↓PLTP; ↓SDC1; ↓SULT2A1; ↑SERPINF1
Antigen Presentation Pathway < 0.0001 0.132 ↓B2M; ↓PSMB8, 9; ↓TAP1, BP
Granulocyte Adhesion and Diapedesis < 0.0001 0.050 ↓CCL8; ↓CXCL2; ↓IL1A; ↓MMP1; ↓SDC1; ↓XCL2; ↑CCL11; ↑IL1RL1; ↑PF4
LXR/RXR Activation 0.0001 0.058 ↓APOA4, B; ↓IL1A; ↓NR1H4; ↓PLTP; ↑IL1RL1; ↑SERPINF1
Serotonin Degradation 0.0051 0.052 ↓ADH4; ↓ALDH1L1; ↓SULT2A1; ↑SULT1A1
Dendritic Cell Maturation 0.0310 0.026 ↓B2M; ↓FCGR3A, B; ↓IL1A; ↑COL1A1; ↑NFKBIA
IL-6 Signaling 0.0284 0.031 ↓IL1A; ↑COL1A1; ↑IL1RL1; ↑NFKBIA
*Ratio: The number of genes differentially expressed within the pathway divided by the total number of genes within the pathway.
†
Genes that exhibited directional influence by treatment within a pathway.
‡
HMGB1: High Mobility Group Box 1. The ↑ arrow is for genes that were up-regulated and the ↓ arrow is for a gene that was down-regulated.
TABLE 4 | Upstream regulators in the intestinal epithelium and how they influence gene expression.
Genes† Upstream Regulators*
Top 5 IL1A IL2 IL4 IL6 IL18 ERK 1/2 IGF 1 GH IFNαR TLR4 IFNγ
RGS2 MAPK 9 PTGS 2 PRTN 3 HRG
CCL2 ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
FABP4 ↓ ↓ ↓ ↓ ↓
IL 18 ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
LPL ↓ ↓ ↓ ↓ ↓ ↓
MMP9 ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
PLAT ↑ ↑ ↑
*Abbreviations for upstream regulators: RGS2, regulator of G protein signaling; PTGS2, Prostaglandin-endoperoxide synthase 2; PRTN3, Proteinase 3; HRG, Histidine Rich Glycoprotein;
ERK1/2, extracellular signal–regulated kinases 1/2; GH, Growth Hormone; IFNαR, Interferon α Receptor; TLR4, Toll-like receptor 4.
†
Abbreviations for genes: CCL2, C-C motif ligand 2; FABP4, fatty acid binding protein 4; LPL, lipoprotein lipase; MMP9, Matrix metallopeptidase 9; PLAT, Plasminogen Activator. The
↑ arrow is for genes that were up-regulated and the ↓ arrow is for a gene that was down-regulated.
Functional analysis of all significant (P< 0.05) genes, with and
without 1.5 fold change within the datasets (BROMO and CON)
was done via IPA library. Functions related to cell movement,
cell development, cell growth and proliferation, cell death,
and overall cellular function and maintenance were the top 5
functional molecular categories (P < 0.001) affected by BROMO
treatment within the intestinal epithelium (Table 6). Whereas,
hematological system development and function, immune cell
trafficking, tissue morphology, skeletal and muscular system
development and overall tissue development were the top
physiological function categories within the epithelium of the
intestine depressed (P < 0.001) in BROMO steers (Table 6). In
the intestinal epithelium all individual functions were depressed
(P < 0.001) in BROMO steers compared with CON steers
(Table 7). Most of these functions were related to immune
cell activation and immune response such as: cell movement
of neutrophils, infiltration, activation, and accumulation
of phagocytes, activation and accumulation of myeloid
cells, quantity of macrophages, and overall inflammation.
Other functions were related to metabolism, quantity of
carbohydrates and proteins, synthesis of lipids, organismal
survival, development of epithelial tissue, and vasculogenesis
(Table 7).
Ingenuity pathway analysis of mesenteric adipose determined
that the top molecular categories were antigen presentation,
protein synthesis, cell death, cell movement, and cell to
cell signaling and interaction (Table 8). Whereas, the top
physiological function categories were organismal survival,
hematological system development and function, tissue
morphology, organismal development, and immune cell
Frontiers in Veterinary Science | www.frontiersin.org 5 September 2020 | Volume 7 | Article 615
McLean et al. Bromocriptine Influence on Bovine Transcriptome
TABLE 5 | Upstream regulators in mesenteric adipose tissue and how they influence gene expression.
Genes† Upstream Regulators*
Top 5 IL1A IL2 IL4 IL6 IL18 IGF-1 GH TLR 4 PRL ERK 1/2
TNF IFNAR IL-1B NF-κβ IFNγ
B2M ↓ ↓ ↓ ↓ ↓
CCL11 ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑
CCND1 ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
COL1α1 ↑ ↑ ↑ ↑ ↑
CXCL2 ↓ ↓ ↓ ↓ ↓ ↓ ↓
GADD45 ↑ ↑ ↑ ↑ ↑ ↑
GBP2 ↓ ↓ ↓ ↓ ↓ ↓ ↓
IDO1 ↓ ↓ ↓ ↓ ↓ ↓ ↓
IL1A ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
IRF1 ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
JUNB ↓ ↓ ↓ ↓ ↓ ↓
MMP1 ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
MYC ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑
NFκβIα ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑
PSMB8 ↓ ↓ ↓ ↓ ↓ ↓
PSMB9 ↓ ↓ ↓ ↓ ↓ ↓ ↓
RSAD2 ↓ ↓ ↓ ↓ ↓
TAP1 ↓ ↓ ↓ ↓ ↓ ↓ ↓
*Abbreviations for upstream regulators: IFNαR, interferon α receptor; GH, growth hormone; TLR 4, toll-like receptor 4; PRL, prolactin; ERK1/2, extracellular signal–regulated kinases 1/2.
†
Abbreviations for genes: B2M, beta-2-microglobulin; CCL11, C-C motif ligand 11; CCND1, cyclin D1; COL1α1, collagen type 1 α chain 1; C-X-C motif, chemokine; CXCL2,
ligand 2; GADD45, growth arrest and DNA damage 45; GBP2, guanine binding protein 2; IDO1, indoleamine 2,3-dioxygenase 1; IRF1, interferon regulatory factor 1; MMP1, Matrix
metallopeptidase 1; NFκβIα, NF-κβ inhibitor α; PSMB8, proteasome subunit beta 8; PSMB9, proteasome subunit beta 9; RSAD2, radical S-adenosyl methionine domain containing 2;
TAP1, transporter 1. The ↑ arrow is for genes that were up-regulated and the ↓ arrow is for a gene that was down-regulated.
TABLE 6 | IPA* bio-functions enriched by significantly expressed genes in the
intestinal epithelium of bromocriptine treated Holstein steers.
Top 5 molecular and cellular
functions
Top 5 physiological system
development and functions
Cellular Movement Hematological System Development
and Function
Cellular Development Immune Cell Trafficking
Cellular Growth and Proliferation Tissue Morphology
Cell Death and Survival Skeletal and Muscular System
Development and Function
Cellular Function and Maintenance Tissue Development
*IPA, Ingenuity Pathway Analysis.
trafficking (Table 8). The complete list of individual functions
influenced by BROMO treatment in the mesenteric adipose is
provided in Supplementary Table 1. Physiologically relevant
functions to the hypothesis of the study (P < 0.001) related to
metabolism, tissue and cell health and growth, cell movement,
and some immune and inflammatory responses were down
regulated (P < 0.001; Table 9). The few immune response
functions that showed activation (P < 0.001) with BROMO
treatment were recruitment of macrophages, activation of
myeloid cells and leukocytes, and proliferation of mononuclear
leukocytes and lymphatic system cells. There were multiple
gastrointestinal disease functions, focused largely around
inflammation, activated due to exposure to BROMO including
enteritis and colitis (Table 9). Functions that were related to
metabolism consisted of mainly lipid metabolism functions,
transport of lipid, cholesterol, and steroids and the quantity of
HDL in the blood. Cellular movement and migration of both
epithelial and smooth muscles cells was depressed in BROMO
steers compared with CON steers (Table 9).
DISCUSSION
The widespread usage of tall fescue for grazing animals makes
the decrease in productivity due to fescue toxicosis economically
important to beef production. Tall fescue (Lolium arundinaceum)
has a symbiotic relationship to a fungal endophyte (Epichloë
coenophiala) which infects mainly the seed head of the plant but
also confers growth and heartiness advantages which increase
the usefulness of tall fescue as a grazing feed source (1). The
endophytic infection creates a source of ergot alkaloids of
which ergovaline is found in the greatest concentrations (26).
Consumption of these associated ergot alkaloids in sufficient
amounts to cause fescue toxicosis in cattle results in a dramatic
reduction in circulating prolactin concentration; a diagnostic tool
used to confirm exposure to detrimental ergot alkaloids (5, 12–
15, 20). Bromocriptine, a synthetic ergopeptine and dopamine
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TABLE 7 | Individual functions* activated or depressed within the intestinal epithelium of Holstein steers treated with bromocriptine compared to saline treated steers.
IPA† Bio-function Functional effect P-value z-Score of activation‡ Genes, n
Carbohydrate Metabolism Quantity of carbohydrate 0.0017 −1.176 4
Cardiovascular System Development Vasculogenesis 0.0009 −1.073 5
Cell-To-Cell Signaling Activation of cells 0.0015 −1.556 5
Activation of myeloid cells < 0.0001 −1.282 4
Activation of phagocytes 0.0001 −1.282 4
Cellular Movement Infiltration by myeloid cells < 0.0001 −1.445 5
Chemotaxis 0.0018 −1.133 4
Cell movement of neutrophils < 0.0001 −1.695 5
Cellular infiltration by phagocytes < 0.0001 −1.067 5
Migration of smooth muscle cells < 0.0001 −1.282 4
Immune Cell Trafficking and Inflammatory Response Accumulation of phagocytes < 0.0001 −1.067 4
Quantity of macrophages < 0.0001 −1.612 4
Accumulation of myeloid cells < 0.0001 −1.192 4
Inflammatory response 0.0008 −1.67 5
Inflammation of absolute anatomical region < 0.0001 −1.533 7
Inflammation of organ < 0.0001 −1.414 10
Synthesis of lipid 0.0043 −1.963 4
Organismal Survival Survival of organism 0.0009 1.138 5
Protein Synthesis Metabolism of protein 0.0026 −1.927 5
Quantity of protein in blood 0.0018 −1.06 4
Tissue Development Development of epithelial tissue 0.0001 −1.103 5
*Functions were selected upon the criteria of having a P value < 0.05 and an absolute value for the z score of activation of > 1.
†
IPA, Ingenuity Pathway Analysis.
‡
A negative z score of activation indicates the function was depressed and a positive z score of activation indicates the functions was activated.
TABLE 8 | IPA* bio-functions enriched by significantly expressed genes in
mesenteric adipose of bromocriptine treated Holstein steers.
Top 5 molecular and cellular
functions
Top 5 physiological system
development and functions
Antigen Presentation Organismal Survival
Protein Synthesis Hematological System Development
and Function
Cell Death and Survival Tissue Morphology
Cellular Movement Organismal Development
Cell to Cell Signaling and Interaction Immune Cell Trafficking
*IPA, Ingenuity Pathway Analysis.
receptor agonist, shares a high degree of structural homology
with ergovaline and has also been shown to reduce circulating
prolactin concentration in cattle (14, 20). More recently we have
shown that 90% of DEG (n = 866) in mammary tissue respond
similarly for both fed fescue-derived alkaloids and BROMO
treated cows (15); indicating that BROMO provides an adequate
model for studying physiological changes in cattle grazing
endophyte-infected tall fescue. In the current study we extend our
finding concerning the effects of BROMO on the transcriptome
to the intestinal epithelium and mesenteric adipose in growing
ruminant animals.
Intestinal Epithelium
Based on the current dataset and previous work (15, 20) in dairy
cows BROMO impacted the intestinal transcriptome less than
that observed in the transcriptome of mesenteric adipose and
the mammary gland. We cannot eliminate the possibility that
the intestinal transcriptome could be differentially influenced
by luminal vs. systemic administration of ergot alkaloids,
however, previous studies have shown that subcutaneous
injections of bromocriptine alter intestinal transit in mice
(27) and both intravenous and intraluminal bromocriptine
stimulated small intestinal absorption of nutrients in multiple
mammalian species (28). Based on selection criteria, RNA-Seq
analysis revealed two DEG within the intestinal epithelium.
These genes were fatty acid binding protein 4 (FABP4)
which was down regulated and UDP-GlcNAc:betaGal Beta-1,3-
N-Acetylglucosaminyltransferase 6 (B3GNT6) which was up
regulated in steers treated with BROMO. Fatty acid binding
protein is known to be involved in transport and metabolism of
long chain fatty acids and overall lipid metabolism (11, 29, 30).
Up regulation of B3GNT6 is indicative of increased lymphocyte
trafficking and homing which may suggested increased immune
activity as reported in other published data (31). Interestingly,
although a limited number of DEG were detected both fit with
previously reported effects of ergot alkaloid exposure.
There were two canonical pathways (LXR/RXR activation,
granulocyte adhesion and diapedesis pathways) depressed in
both tissue types. These pathways provide further evidence
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TABLE 9 | Individual functions* activated or depressed within mesenteric adipose of Holstein steers treated with bromocriptine compared to saline treated Holstein steers.
IPA† Functional effect P-value z-Score of activation‡ Genes, n
Bio-function
Antigen Presentation Activation of leukocytes < 0.0001 1.028 19
Proliferation of mononuclear leukocytes 0.0041 2.012 18
Proliferation of lymphatic system cells 0.0040 1.8 19
Gastrointestinal Disease Gastroenteritis 0.0014 1.588 13
Enteritis 0.0025 1.352 12
Colitis 0.0031 1.741 11
Inflammation of gastrointestinal tract 0.0016 1.588 13
Abnormality of large intestine 0.0024 1.969 12
Hematological Disease, Development, and Function Blood protein disorder 0.0008 1.954 16
Lymphoproliferative disorder < 0.0001 1.475 47
Quantity of hematopoietic progenitor cells 0.0012 −1.226 14
Quantity of phagocytes < 0.0001 −1.35 16
Quantity of macrophages < 0.0001 −1.117 11
Hematological System Development and Function Quantity of T lymphocytes 0.0035 −1.476 15
Quantity of lymphocytes 0.0011 −1.084 20
Quantity of blood cells < 0.0001 −2.148 34
Quantity of granulocytes 0.0004 −1.551 12
Quantity of leukocytes < 0.0001 −1.509 29
Quantity of mononuclear leukocytes 0.0007 −1.399 21
Quantity of myeloid cells < 0.0001 −1.144 18
Humoral Immune Response Quantity of immunoglobulin 0.0022 −1.261 10
Inflammatory Disease and Response Inflammation of body cavity < 0.0001 1.258 26
Inflammation of absolute anatomical region < 0.0001 1.97 33
Organismal Development Growth of organism 0.0006 1.16 22
Organismal Injury and Abnormalities Cytosis 0.0011 −1.362 12
Tissue Morphology Quantity of cells < 0.0001 −1.519 49
*Functions were selected upon the criteria of having a P value < 0.05, more than 10 genes identified within, and an absolute value for the z score of activation of > 1.
†
IPA, Ingenuity Pathway Analysis.
‡
A negative z score of activation indicates the function was depressed and a positive z score of activation indicates the functions was activated.
that alkaloid exposure negatively impacts immune function.
Granulocyte (neutrophils, basophils, and eosinophils) adhesion
and diapedesis are more involved in the efficiency and activity
of the immune response within these tissues. This is supported
by depressed movement of neutrophil identified by individual
function analysis within IPA. Most of the other intestine specific
pathways influenced by alkaloid exposure have a role in the
inflammatory response: the inflammasome pathway, HMGB1,
and atherosclerosis signaling. Interestingly, HMGB1 signaling
and monocyte infiltration can also influence expression of
adhesion molecules (32). While this was not evident in DEGs,
upon further analysis we found both IL18 and C-C Motif
Chemokine Ligand 2 (CCL2) tended to be down regulated
and plasminogen activator (PLAT) tended to be up regulated.
These genes were sufficient to identify the HMGB1 pathway as
significantly affected and may suggest that BROMO treatment
may impact barrier function of the intestine similar to results in
mice (33).
Cellular and physiological functions identified from these
datasets were indicative of effects on cell movement, cell and
tissue growth and development, and cell survival. Functional
analysis using IPA indicated migration of smooth muscle cells
was influenced in BROMO steers. This is meaningful in that
intravenous administration of ergot alkaloids has also resulted
in an immediate inhibition of muscle contractions in the
forestomach of ruminants (34). Thus, these effects could be
due to direct actions of alkaloids on myenteric neurons and
on smooth muscle cells (35). The most significant physiological
function identified was hematological system development and
function. Initially this was thought to be changes in vascularity
which would agree with previously published research (2, 10, 36–
39). However, a closer look at individual functions revealed that
circulating immune surveillance rather than angiogenesis was
impacted within the intestinal epithelium. Because vasoactivity
was not measured in the current study it is equivocal whether
fescue alkaloid-induced vasoconstriction, i.e., predominantly
ergovaline, fails to result in DEG or whether the dose of BROMO
used in the current study was below the threshold to induce
vasoconstriction in visceral blood vessels as previously reported.
The latter can be supported by the fact that the dose of BROMO
used in the current study had no impact on the ability of treated
steers to consume 1.5 × net energy for maintenance daily.
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Whereas, previous studies using fescue seed have shown much
more severe effects on feed intake in cattle (8, 9, 11).
Mesenteric Adipose
There was a greater number of DEG due to BROMO in the
mesenteric adipose with 20 DEG (14 down regulated and 6 up
regulated). Down regulated genes functions included enzymes,
transporters, ion channel, cytokines, and other immune response
molecules. The 4DEG identified as an enzymes were Cytochrome
P450 Family 4 Subfamily F Member 2 (CYP4F2), involved
in fatty acid and cholesterol synthesis; Activation Induced
Cytidine Deaminase (AICDA), regulation of immunoglobulin
somatic hypermutation and class switch recombination (CSR),
processes required for B-cell development of high affinity
antibodies; cadherin 16 (CDH16) an adhesion molecule, and
Glycosyltransferase 1 Domain Containing 1 (GLT1D1) for which
an exact function is unknown. The transporters down regulated
in adipose were both members of the solute carrier family,
SLC9A2 and SLC26A5, and are involved in cation and anion
transport, respectively. In addition to SLC9A2, which is a
sodium/hydrogen exchanger, Acid Sensing Ion Channel Subunit
Family Member 5 (ASIC5) a Na+ ion channel was also down
regulated. The down regulation of SLC9A2 which functions
to counter adverse environmental conditions, specifically pH
regulation is intriguing but the exact role cannot be determined
in the current dataset.
Maruo et al. (40) suggested activation of a negative feedback
mechanism in the intestine and liver of pigs fed ergot alkaloids
which also had a down regulation of toll-like receptors and a
variety for cytokines including IL-6 and Tumor Necrosis Factor
α (TNFα). In pigs fed ergot alkaloids tissues may be attempting
to restore barrier function by up regulating mRNA expression
of adhesion proteins such as occludins, claudins 3 and 4, and
others (40). Accordingly, the down regulation of most genes
in the current study may exemplify this purposed feedback
mechanism within the adipose and reflect the drive to return to
normal physiological conditions. In contrast, alkaloid ingestion
has been reported to cause increased inflammation (31) and
decrease overall immune competency (41). These conflicting
results were also apparent in our data. However, an explanation
is not immediately apparent but there are still clear alterations in
immunological response and function.
The six up regulated DEG had identified functions of
enzyme activity [Monooxygenase DBH Like 1 (MOXD1)],
molecular transport [Sortilin Related VPS10 Domain Containing
Receptor 2 (SORCS2); Solute Carrier Family 11 Member 1
(SLC11A1)], transmembrane receptor [Delta/Notch Like EGF
Repeat (DNER)], cytokine [Platelet Factor 4 (PF4)] and other
unknown functions [Lymphocyte Antigen 6 FamilyMember G5B
(LY6G5B)]. In contrast, mRNA and protein expression in the
intestine and liver of swine fed ergot alkaloids exhibited up
regulation of adhesion molecules (40); however, CSH16 was the
only DEG identified that has adhesion properties and it was down
regulated. This may be a differential effect of alkaloid exposure
between species but may simply confirm the wide variety of
physiological functions influenced by ergot alkaloids.
The canonical pathways influenced by BROMO treatment
were largely focused on inflammation, immune response, and
lipid metabolism. Pathway identification from IPA utilized all
significantly expressed genes (P < 0.05) with and without a fold
change>1.5. The LXR/RXR activation and granulocyte adhesion
and diapedesis pathways were depressed in the mesenteric
adipose as well as the intestine. Inhibition of the LXR/RXR
heterodimer would directly modulate the initiation of immune
and inflammatory responses in macrophages (42). Individual
functions support the influence on macrophage function from
recruitment and movement to proliferation and overall quantity.
Whereas, granulocyte (neutrophils, basophils, and eosinophils)
adhesion and diapedesis are more involved in the efficiency and
activity of the immune response within these tissues. Unlike
in the intestine, overall granulocyte quantity and recruitment
were depressed in adipose tissue of these steers rather than
neutrophils specifically. Genes involved with the compliment
system (SERPINB2 and C8A), chemokine secretion (CXCL2 and
PF4), and immunoglobulin function (AICDA and HEPACAM2)
were all down regulated DEG except for PF4 which was one of
a fed up regulated DEG in adipose tissue. Further work needs
to be completed to fully understand the role and mechanisms
of DEG within these pathways and how ergot alkaloid exposure
changes the function of these pathways and overall physiology of
the animal.
Accumulation of ergot alkaloids in adipose tissue has
been reported to disrupt or alter lipid metabolism (30).
Both CYP4F2 and NR1H4 were down regulated in the
current dataset. Lipid and bile acid synthesis were depressed
with down regulation of CYP4F2 and NR1H4 and further
supported by identification of HDL and LDL inhibition
within LXR/RXR pathways. These data begin to identify
specific genes and a putative mechanism to explain how
alkaloids, specifically BROMO, influence adipocytes and
lipid metabolism.
LPS/IL-1 mediated inhibition of RXR and IL-6 signaling were
activated and FXR/RXR activation, antigen presentation, and
dendritic cell maturation were depressed by alkaloid exposure.
Canonical pathways influenced by BROMO treatment, like DEG,
indicate opposing effects on immune response. Specifically, the
influence of ergot alkaloids on immune cell trafficking, cellular
movement, and immune response within abdominal tissues.
Previously reported data demonstrated that ergot alkaloids
increased inflammation but decreased overall immune function
in steers that grazed endophyte-infected tall fescue as evidenced
by lower Cu status, depressed immune-competency, decreased
major histocompatibility complex class II expression, and
macrophage phagocytosis activity (41). The current dataset
agrees with previous literature (41) that exposed cattle could
have a decreased immune response through inhibition of
associated genes and other pathways associated with a variety
of mechanisms. However, our data doesn’t supply any further
evidence for increased inflammation (31, 41). This dichotomy
in the literature is similar to the conflicting DEG, pathways,
and functions observed in the current dataset and thus requires
more work to completely elucidate the mechanisms behind
this contradiction.
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In the current dataset, the serotonin degradation pathway
(Table 2) was depressed by BROMO treatment in the adipose
which is consistent with the known interaction between
bromocriptine (43) or alkaloids (44) and serotonin metabolism.
Specifically, ergot alkaloids have been reported to interact with
serotonin receptors in vascular smooth muscle (19, 45, 46).
Expression of the serotonin receptor 5HTR2A and 5HTR4 in
gastrointestinal smooth muscle was reduced in steers treated
with ergot alkaloids compared with control steers (47). Serotonin
receptor down regulation is likely due to alkaloids binding
to the receptor. Bromocriptine has a strong affinity for the
5HTR2A receptor (48). Therefore, BROMO is likely inhibiting
the serotonin degradation pathway through antagonistic activity
within the mesenteric adipose after exposure to BROMO. These
data and that from Klotz et al. (47) suggest an interactive role
of the adipose, intestine, and ergot alkaloids throughout the
serotonin pathway from ligand to receptor.
Surprisingly, there were limited pathways identified by
the current dataset specifically involved with angiogenesis or
vascularity. As discussed earlier, alkaloid exposure has been
reported to constrict blood vessels (2) and flow (10, 36–39) in
other datasets. None of the DEGs identified had a direct effect
on vascularity but CD8A, CXCL2, C8A, SERPINB2, AICDA,
HEPCAM2, and PF4 are directly involved in immune system
response and function. This may suggest that abdominal effects,
such as necrotic fat, are a result of persistent activation of the
immune system vs. vasoconstriction as seen in peripheral tissues
(2, 6, 7, 9).
In the mesenteric adipose compared with the intestinal
epithelium there was a greater number and variety of functions
influenced by BROMO treatment; however most functions
identified represented cell movement and survival, immune
cell trafficking, tissue/organismal development, morphology, and
survival. Mulac and Humpf (49) demonstrated apoptotic effects
of ergot alkaloids on human primary cells in culture which
may help to explain the inhibition of cell survival. Functions
related to overall quantity, recruitment, and movement of
macrophages along with other leukocytes were identified by
functional analysis in the current dataset. Macrophages within
adipose tissue are generally found scattered or in crown-
like structures around dead adipocytes (48). These crown-like
structures were differentially expressed in abdominal fat depots
compared with subcutaneous and pelvic adipose of obese (50) or
leptin and leptin receptor deficient mice (51). These structures
within adipose may be a mechanism responsible for necrotic
fat depot development but more likely are functioning to clear
necrotic adipocytes. In the current dataset, more work needs
to be completed to know if the macrophages were in crown-
like structures associated with deceased adipocytes and if this a
possible mechanism in the formation of necrotic fat depots rather
than vasoconstriction.
The influence of BROMO on lipid metabolism is likely due,
indirectly, to the decrease in prolactin (52). Connor et al. (53)
found exposure to shortened day lengths decreased circulating
prolactin which led to decreased acyl-CoA dehydrogenase. As the
first step in β-oxidation acyl-CoA dehydrogenase would reduce
fatty acids (53) but have also been associated with increased
hepatic triacylglycerol (54) and non-esterified fatty acids (54, 55).
Alterations in lipid metabolism due to bromoergocriptine did
not impact milk fat in lactating dairy cows (56). Thus, indicating
prolactin alters fatty acid (52) and cholesterol (8, 57) metabolism.
However, in addition to those mediated through prolactin, it
is possible that BROMO treatment and ergot alkaloids have a
more direct effect on lipid metabolism. These data also indicate
BROMO can alter adiposemetabolism and function which would
change the morphology of adipose tissue and influence immune
surveillance by leukocytes located within this tissue.
In summary, exposure of Holstein steers to systemic
bromocriptine resulted in decreased plasma prolactin
concentration which is what occurs when steers graze endophyte-
infected tall fescue or are administered ergot alkaloids. RNA-Seq
analysis revealed that exposure to a synthetic alkaloid was
influential on pathways and functions involved with immune
cell trafficking, inflammatory responses, and lipid metabolism
compared with other physiological pathways and functions.
These data provide insight into the specific tissue responses and
potential pathways and genes affected and thereby begin the
process of elucidating the mechanisms behind compromised
health and productivity of animals grazing ergot alkaloids.
However, further and more specific analyses need to be
conducted to completely understand the mechanisms behind the
negative effects of animals exposed to ergot alkaloids.
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